Overview
- Revenue came in at $172.1 million, down 10.8% year over year and below the $177.6 million consensus.
- Adjusted EPS posted a $0.44 loss versus an expected profit, and the GAAP net loss of $58 million reflected a $53 million income tax charge.
- Total subscribers reached 3.0 million with 124,000 in Clinical, as Clinical revenue rose 35% to $26 million and the Behavioral business remained pressured.
- Fiscal 2025 guidance inched up to $695 million–$700 million in revenue and $145 million–$150 million in Adjusted EBITDA, trailing some analyst projections.
- Following a restructuring, total debt fell by more than 70% (about $1.1 billion) and cash rose to $170 million, and the stock gained roughly 13% intraday to $37.64.